Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. One out of the three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 7 points (0.0%) at 17,620 as of Tuesday, Nov. 11, 2014, 12:00 PM ET. The NYSE advances/declines ratio sits at 1,391 issues advancing vs. 1,566 declining with 174 unchanged. The Wholesale industry currently sits down 0.3% versus the S&P 500, which is unchanged. A company within the industry that fell today was W W Grainger ( GWW), up 0.5%. TheStreet would like to highlight 3 stocks pushing the industry higher today: 3. Omnicare ( OCR) is one of the companies pushing the Wholesale industry higher today. As of noon trading, Omnicare is up $1.11 (1.6%) to $69.84 on heavy volume. Thus far, 1.5 million shares of Omnicare exchanged hands as compared to its average daily volume of 938,600 shares. The stock has ranged in price between $69.45-$71.51 after having opened the day at $70.08 as compared to the previous trading day's close of $68.73. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. Omnicare, Inc. operates as a healthcare services company that specializes in the management of pharmaceutical care in the United States and Canada. It operates through two segments, Long-Term Care Group and Specialty Care Group. Omnicare has a market cap of $6.7 billion and is part of the health care sector. Shares are up 13.9% year-to-date as of the close of trading on Monday. Currently there are 5 analysts who rate Omnicare a buy, no analysts rate it a sell, and 1 rates it a hold. TheStreet Ratings rates Omnicare as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Omnicare Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.